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ABSTRACT cDNA clones coding for the ,B subunit of rat
brain type II Ca2+/calmodulin-dependent protein kinase were
isolated and sequenced. The clones, including one containing
the entire coding region, hybridize at high stringency to a single
band of poly(A)+ RNA of length 4.8 kilobases. The subunit
coded for by the clones was identified by in vitro transcription
of the cDNA followed by translation of the resulting RNA. The
DNA sequence of the clones contains a single long open reading
frame (1626 nucleotides) coding for a protein of 542 amino
acids with a molecular weight of 60,333, the amino-terminal
half of which is homologous to several other protein kinases.
Potential ATP- and calmodulin-binding domains were identi-
fied. Two independent clones contain an identical 45-nucleotide
deletion, relative to the clones described above, resulting in a
shorter open reading frame coding for a protein of molecular
weight 58,000. This suggests that the minor, 58-kDa 13' subunit
of the type II Ca2+/calmodulin-dependent kinase may be
synthesized on a separate message.
The type II Ca2+/calmodulin-dependent protein kinase (type
II CaM kinase) is one of the most abundant brain protein
kinases (1-3). It is a member of a family of broad-specificity
protein kinases of similar structure and substrate specificity
that occur at lower concentrations in other tissues (4-6). This
kinase is particularly highly expressed in forebrain neurons
(3, 7), where it is present throughout the neuron and appears
to be concentrated in postsynaptic densities (8-10). The
properties of the kinase suggest that it can act as a calcium-
triggered switch and that it could, therefore, encode certain
long-lasting changes in synapses that are produced by brief
bursts of synaptic activity (11, 12). The predominant fore-
brain form is composed of approximately nine 50-kDa a
subunits and three 60-kDa 3 subunits, both of which bind
calmodulin and appear to be catalytic. We have isolated
cDNA clones that code for the 13 subunit and deduced its
amino acid sequence from the nucleotide sequence of the
coding region.
METHODS
Materials. DNA polymerase I Klenow fragment and re-
striction endonucleases were purchased from Boehringer
Mannheim Biochemicals; oligo(dT)-cellulose, M13 hybrid-
ization probe primer, and protein A-Sepharose, from Phar-
macia; [a-32P]dATP and [35S]methionine, from Amersham;
SP6 RNA polymerase, from New England Biolabs; and
plasmid pGEM-2, from Promega Biotech. Two oligo(dT)-
primed rat brain cDNA libraries, constructed in the vectors
Xgtll (13) and XgtlO (14), were a gift of David Anderson of
Columbia University.
Screening of cDNA Libraries. The Xgtll library (2.5 x 105
plaques) was screened as described by Moon et al. (15) with
two rabbit polyclonal antisera, one generated against whole
purified type II CaM kinase (Annette) and the other against
electrophoretically purified (3 subunit (Darcy) (16). Two
cDNA clones coding for proteins that reacted with both
antisera were isolated.
The XgtlO library was screened by plaque hybridization
(17) with a 32P-labeled 600-base restriction fragment of one of
the Xgtl1 inserts. Conditions for prehybridization, hybrid-
ization, and washing were essentially as described by Mein-
koth and Wahl (18). Hybridization was done in 50%o form-
amide in a buffer containing 0.75 M NaCl at 420C and was
followed by washes with a buffer containing 18 mM NaCl at
420C. Twenty-three additional cDNA clones were isolated
from 4 x 105 plaques screened.
DNA Sequencing. Detailed restriction maps of the cDNAs
were constructed, and appropriate restriction fragments were
isolated by agarose gel electrophoresis (19) and ligated into
the' M13 vectors mpi8 and mp19 for sequencing (20). DNA
sequences were determined by the dideoxy chain-termina-
tion method (21) with either a 15-nucleotide universal primer
or an 18-nucleotide 3-subunit-specific primer.
Preparation of Hybridization Probes. Hybridization probes
with specific activities of 1-2 x 10 cpm/,ug of insert were
prepared from the single-stranded DNA ofM13 subclones by
extension of a primer with DNA polymerase I Klenow
fragment in the presence of [a-32P]dATP as described by
Messing (20).
Analysis of Endogenous Messages. RNA was purified from
whole rat brain and from forebrain and cerebellum as de-
scribed by Chirgwin et al. (22). Poly(A)+ RNA was purified
by two cycles of chromatography on oligo(dT)-cellulose (23),
fractionated by electrophoresis in 1% agarose gels containing
2.2 M formaldehyde, and transferred to nitrocellulose (19).
Hybridization of probes with the immobilized RNA was
performed as described above for plaque hybridization.
In Vitro Translation and Immunoprecipitation of Products.
A rabbit reticulocyte lysate translation system was prepared
as described by Jackson and Hunt (24). RNA was translated
in the presence of [35S]methionine. Translation products
were diluted with 3 volumes ofNET (50mM Tris, pH 7.5/150
mM NaCl/10 mM EDTA) containing 1% (vol/vol) Nonidet
P-40, then precleared by stirring with one volume of protein
A-Sepharose beads and 0.2 volume of rabbit anti-mouse IgG
(1.5 mg/ml) for 2 hr at 4°C. The beads were sedimented, and
the supernatant was transferred to a fresh tube and incubated
with 80 ng of pure carrier type II CaM kinase and 2.5 ,l (-50
,g) of anti-kinase monoclonal antibody 4A11 (3) for 4 hr at
0°C. Rabbit anti-mouse IgG (7.5 ul) and protein A-Sepharose
(40 ,u) were added, and the reaction continued for 2 hr at 4°C
Abbreviation: type II CaM kinase, type II Ca2+/calmodulin-depen-
dent protein kinase.
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with mixing. The beads were sedimented and washed six
times with NET containing 1% Nonidet P-40 and twice with
NET. Immunoprecipitated proteins were released by boiling
in NaDodSO4 sample buffer and analyzed by NaDodSO4/
polyacrylamide gel electrophoresis.
In Vitro Transcription. The longest XgtlO cDNA insert
[X10,85-2; 1.8 kilobases (kb)] was excised with EcoRI and
inserted into the plasmid pGEM-2, which contains the SP6
promoter. The recombinant plasmid was linearized with
HindIll and transcripts were synthesized with SP6 RNA
polymerase as described by Melton et al. (25).
RESULTS
Selection of cDNA Clones. cDNA clones coding for the (3
subunit of brain type II CaM kinase were identified by
screening a rat brain cDNA library constructed in the
expression vector Xgtll with two anti-kinase rabbit antisera.
Both antisera react strongly with the (3 subunit and weakly
with the a subunit on immunoblots (16). Two cDNA clones,
both of which code for fusion proteins that react with both
antisera, were isolated. The reaction was blocked by preab-
sorption ofthe antisera with pure type II CaM kinase. A XgtlO
library was then screened with a 600-base restriction frag-
ment of one of the Xgtll inserts, resulting in selection of 23
additional cDNA clones. The seven clones with the longest
inserts (0.85-1.8 kb) were characterized further.
Restriction site analysis of these clones generated a con-
sistent map 1.8 kb in length (Fig. 1). Although some of the
clones extended outside the 1.8-kb region, the restriction
maps in these flanking regions were not consistent. These
regions may represent artifacts due to the ligation of two or
more unrelated sequences during the construction of the
XgtlO library (D. Anderson, personal communication). Only
restriction sites and nucleotide sequences that were obtained
from at least two independent clones are included in the
overall restriction map (Fig. 1) and nucleotide sequence (Fig.
3).
Subunit Specificity. One cDNA clone, X10P35-2, included
the entire 1.8-kb region shown in Fig. 1 and was used to
establish the subunit coded for by the cDNA clones. We first
established that there is a differential distribution ofmessages
for the two subunits between the forebrain and the cerebel-
lum. Equal amounts of RNA from each of these two regions
were translated in vitro. Immunoprecipitation ofthe products
with an anti-kinase monoclonal antibody demonstrated that
the a-subunit message is more abundant in the forebrain than
in the cerebellum, whereas the (-subunit message is equally
distributed between them (Fig. 2A). This is consistent with
the different subunit composition of the enzymes purified
from these two brain regions (16, 26). The distribution of the
messages recognized by the X10P5-2 insert was determined
by blot analysis of equal amounts of forebrain and cerebellar
RNA (Fig. 2B). The insert hybridizes primarily with a 4.8-kb
band (thick arrow) that is roughly equally distributed between
the forebrain and the cerebellum, as is the 3-subunit message.
In addition, it hybridizes with a 5.4-kb band (thin arrow)
which is more abundant in the forebrain than in the cerebel-
lum. Hybridization with this band is eliminated by washing
the blot at higher stringency (18 mM NaCl, 65°C). We believe
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FIG. 2. Demonstration of subunit specificity of the type II CaM
kinase cDNA clones. (A) Fifteen micrograms ofcerebellar (CER) and
forebrain (FB) total RNA was translated in vitro in 90 "I of a rabbit
reticulocyte lysate translation mixture, containing 63 ,uCi (1 Ci = 37
GBq) of [35S]methionine, for 90 min at 30°C. The translation products
were immunoprecipitated with monoclonal antibody 4A11. Positions
ofthe a and , subunits are marked. (B) Five micrograms of cerebellar
(CER) and forebrain (FB) poly(A)+ RNA was resolved in a 1%
agarose gel containing 2.2 M formaldehyde and transferred to a
nitrocellulose filter. The filter was probed with 0.5 ,g of a 32P-labeled
single-stranded X10#5-2 probe (specific activity 2 x 108 cpm/,ug of
insert). Major and minor bands are indicated by thick and thin
arrows, respectively. Size markers used were Escherichia coli and
sea urchin ribosomal RNAs. (C) Ten micrograms of forebrain
poly(A)+ RNA was translated in vitro in 200 p.1 of a rabbit reticulo-
cyte lysate translation mixture, containing 80 ,uCi of [35S]methionine,
for 90 min at 30°C. Two microliters of the total translation product(AW, TOTAL TRANS.) was loaded directly on a NaDodSO4/
polyacrylamide gel and the remainder (198 Aml) was immunoprecipi-
tated with monoclonal antibody 4A11 (A', 4A11 IPPT.) prior to
loading on the gel. One-tenth microgram of the SP6 in vitro transcript
of cDNA insert X10#5-2 was translated in vitro in 20 ,ul of a rabbit
reticulocyte lysate translation mixture, containing 8.0 ,uCi of [35S]_
methionine, for 90 min at 30°C. Two microliters of the total
translation product (SP6, TOTAL TRANS.) was loaded directly on
the gel, and 0.4 ,ul ofthe translation product was immunoprecipitated
with monoclonal antibody 4A11 (SP6, 4A11 IPPIT.) prior to loading
on the gel. The 45-kDa protein present in the total translation
products is an endogenous reticulocyte protein labeled in the absence
of exogenous RNA (24).
the 5.4-kb message codes for the a subunit, since it has the
same size and distribution as a message recognized by two
a-subunit-specific oligonucleotide probes (data not shown).
These results suggest that the clones code for the (3 subunit.
More definitive evidence was obtained by examining the
translation product coded for by the X10,35-2 insert. The
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FIG. 1. Composite restriction map of seven independent type II CaM kinase cDNA clones. Region of vertical stripes indicates the position
of the longest open reading frame. Scale gives length in base pairs.
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insert was transcribed in vitro with SP6 RNA polymerase.
The resulting message, when translated in vitro, coded for a
single 60-kDa protein (Fig. 2C). This protein was immuno-
precipitated by an anti-kinase monoclonal antibody and
comigrated with the subunit immunoprecipitated from the
in vitro translation products of brain poly(A)+ RNA. These
results indicate that the X1lO/5-2 insert codes for the ,/ subunit
of the type II CaM kinase and includes the entire coding
region.
Nucleotide Sequence. The nucleotide sequence of the 3-
subunit cDNA clones is shown in Fig. 3 along with the
deduced amino acid sequence for the longest open reading
frame. The encoded protein contains 542 amino acids and has
a molecular weight of 60,333. Two of the seven /-subunit
cDNA clones that have been sequenced have an identical
45-nucleotide deletion within the region coding for the
carboxyl-terminal half of the protein. This deletion, enclosed
in a box in Fig. 3, does not disrupt the open reading frame and
Proc. Natl. Acad. Sci. USA 84 (1987)
may represent an alternatively spliced 3-subunit message
(see Discussion).
Sequence Homologies. The amino acid sequence deduced
from the /3-subunit cDNA clones was compared to the
sequences in the National Biomedical Research Foundation
protein sequence data base.* The top nine alignment scores
were all for protein kinases or protein kinase-related proteins.
The homologies are all within a sequence of about 300 amino
acids in the amino-terminal half of the subunit. When
properly aligned (Fig. 4), the subunit is identical with
corresponding amino acids of the y subunit of phosphorylase
b kinase, myosin light chain kinase, and the catalytic subunit
of cAMP-dependent protein kinase at 38%, 31%, and 27% of
their amino acid positions, respectively. If conservative
*Protein Identification Resource (1986) Protein Sequence Database
(Nati. Biomed. Res. Found., Washington, DC), Release 7.0.
-62 GG AGCCGGAGTC GCCGCCGCCC GAGCGCAGCC GAGCGCACGC CGAGCCCAAT CGCCACCGCC
1 ATG GCC ACC ACG GTG ACC TGC ACC CGT TTC ACG GAC GAG TAC CAG CTA TAC GAG GAT ATT GGC AAG GGG GCT TTC TCT GTG GTC CGA CGC
1 Met Ala Thr Thr Val Thr Cys Thr Arg Phe Thr Asp Glu Tyr Gln Leu Tyr Glu Asp Ile Gly Lys Gly Ala Phe Ser Val Val Arg Arg
91 TGT GTC AAG CTC TGC ACC GGC CAT GAG TAT GCA GCT AAG ATC ATT AAC ACC AAG AAG CTG TCA GCT AGA GAT CAC CAG AAG CTG GAG AGG
31 Cys Val Lys Lsu Cys Thr Gly His Glu Tyr Ala Ala Lys Ile Ile Asn Thr Lys Lys Leu Ser Ala Arg Asp His Gln Lys Leu Glu Arg
181 GAG GCT CGG ATC TGC CGC CTG CTG AAG CAT TCC AAC ATT GTA CGC CTC CAT GAC AGC ATC TCT GAA GAG GGC TTC CAC TAC CTG GTC TTC
61 Glu Ala Arg Ile Cys Arg Leu Leu Lye His Ser Asn Ile Val Arg Lou His Asp Ser Ile Ser Glu Glu Gly Phe His Tyr Lou Val Phe
271 GAC CTG GTC ACT GGT GGG GAG CTC TIm GAA GAC ATT GTG GCG AGA GAG TAC TAC AGT GAG GCT GAC GCC AGT CAC TGT ATC CAG CAG ATC
91 Asp Leu Val Thr Gly Gly Glu Leu Phe Glu Asp Ile Val Ala Arg Glu Tyr Tyr Ser Glu Ala Asp Ala Ser His Cys Ile Gln Gln Ile
361 CTG GAG GCT GTT CTC CAT TGT CAC CAA ATG GGG GIC GTC CAC AGA GAC CTC AAG CCT GAA AAC CTC CTG CTC GCC AGC AAA TGC AAA GGG
121 Leu Glu Ala Val Leu His Cys His Gln Met Gly Val Val His Arg Asp Lou Lys Pro Glu Asn Leu Leu Leu Ala Ser Lys Cys Lys Gly
451 GCC GCA GTG AAA CTG GCA GAC TTC GGC CTG GCC ATC GAG GTT CAG GGA GAC CAG CAG GCA TGG TTT GGA T'm GCG GGA ACA CCA GGC TAC
151 Ala Ala Val Lys Leu Ala Asp Phe Gly Leu Ala Ile Glu Val Gln Gly Asp Gln Gln Ala Trp Phe Gly Phe Ala Gly Thr Pro Gly Tyr
541 CTG TCT CCC GAA GTT CTT CGG AAG GAG GCC TAT GGC AAA CCA GTG GAT ATC TGG GCA TGT GGG GTG ATC CTG TAT ATC CTG CTG GTG GGA
181 Leu Ser Pro Glu Val Leu Arg Lys Glu Ala Tyr Gly Lys Pro Val Asp Ile Trp Ala Cys Gly Val Ile Leu Tyr Ile Leu Lou Val Gly
631 TAC CCA CCT TTC TGG GAT GAG GAC CAG CAC AAG CTG TAC CAG CAG ATC AAG GCT GGG GCC TAT GAC TTC CCA TCC CCC GAG TGG GAC ACC
211 Tyr Pro Pro Phe Trp Asp Glu Asp Gln His Lys Leu Tyr Gln Gln Ile Lys Ala Gly Ala Tyr Asp Phe Pro Ser Pro Glu Trp Asp Thr
721 GTT ACC CCT GAA GCC AAA AAC CIC ATC AAC CAG ATG TTG ACC ATC AAC CCC GCC AAG CGC ATC ACG GCC CAC GAG GCC CTG AAG CAC CCA
241 Val Thr Pro Glu Ala Lys Asn Leu Ile Asn Gln Met Leu Thr Ile Asn Pro Ala Lys Arg Il. Thr Ala His Glu Ala Leu Lys His Pro
811 TGG GTC TGC CAA CGA TCC ACG GTG GCC TCC ATG ATG CAC AGA CAG GAG ACT GTG GAA TGT CTG AAG AAG TTC AAT GCA AGG AGG AAG CTC
271 Trp Val Cys Gln Arg Ser Thr Val Ala Ser Met Met His Arg Gln Glu Thr Val Glu Cys Leu Lys Lys Phe Asn Ala Arg Arg Lys Leu
901 AAG GGA GCC ACT CTC ACC ACT ATG CTG GCC ACA CGG AAT TIC TCA GTG GGC AGA CAG ACC ACC GCT CCG GCC ACA ATG TCC ACC GCG GCC
301 Lys Gly Ala Ile Leu Thr Thr Met Leu Ala Thr Arg Asn Phe Ser Val Gly Arg Gln Thr Thr Ala Pro Ala Thr Met Ser Thr Ala Ala
991 TCC GGC ACC ACC ATG GGG CTG GTG GAA CAA GCC AAG AGT TTA CTC AAC AAG AAA GCA GAC GGA GTC AAG CCC CAG ACA AAC AGC ACC AAA
331 Ser Gly Thr Thr Met Gly Leu Val Glu Gln Ala Lye Ser Leu Lou Asn Lys Lys Ala Asp Gly Val Lys Pro Gln Thr Asn Ser Thr Lys
1081 AMC AGC TCG aCC ATC ACC AGC CCC AAA GGA TCC CTC CCT CCT GCC GCC CTG [GAG CCT CMA ACC ACC GTT ATC CAT AAC CCA GTG GAC GGC
361 Asn Ser Ser Ala Ile Ihr Ser Pro Lys Gly Ser Leu Pro Pro Ala Ala Leu Glu Pro Gln Thr Thr Val Ile His Asn Pro Val Asp Gly
1171 ATT AGGM ICT TCC GAC AGC AC AAC ACA ACC ATA GAG GAC GAA GAT GCC AAA 0CC CGG AAG CAG GMA ATC ATC AAG ACC ACA GAG CAG
391 Ile Lys Glu Ser Ser Asp Ser Thr Asn Thr Thr Ile Glu Asp Glu Asp Ala Lys Ala Arg Lys Gln Glu Ile Ile Lys Thr Thr Glu Gln
1261 CTC ATC GAG GCC GTC AAC AAC GSC GAC TI! GAG GCC TAT GCG AAA ATC TGT GAC CCA GCC CTG ACC ICA m'T GAG CCT GAA GCT CTG GGC
421 Leu Ile Glu Ala Val Asn Asn Gly Asp Phe Glu Ala Tyr Ala Lys Ile Cys Asp Pro Gly Leu Thr Ser Phe Glu Pro Glu Ala Leu Gly
1351 AAC CTG GIC GAA GGG ATG GAT TTC CAC AGA TTC TAC ImT GAG AAC CG CTG 0CC AAG AAC AGC AAG CCG ATC CAC ACC ACT ATC CT0 AAC
451 Asn Leu Val Glu Gly Met Asp Phe His Arg Phe Tyr Phe Glu Asn Leu Leu Ala Lys Asn Ser Lys Pro Ile His Thr Thr Ile Leu Asn
1441 CCG CAC GTG CAC GTC ATC GGC GAG GAT GCA GCC TGC ATC GCT TAC ATC CGC CTC ACA CAG TAC ATC GAC GGC CAG GGC AGA CCC CtC ACC
481 Pro His Val His Val Ile Gly Glu Asp Ala Ala Cys Ile Ala Tyr Ile Arg Leu Thr Gln Tyr Ile Asp Gly Gln Gly Arg Pro Arg Thr
1531 AGC CAG TCC GAA GAG ACC CGT GTG TGG CAC CGC CCC GAC GGC AAG TGG CAG AAT GTC CAT TTC CAC TGC TCG GCC GCT CCA GTG 0CC CCA
511 Ser Gln Ser Glu Glu Thr Arg Val Trp His Arg Pro Asp Gly Lye Trp Gln Asn Val His Phe His Cys Ser Gly Ala Pro Val Ala Pro
1621 CTG CAG TGA GAGCTGCGCC TGGTTTCACC GGACAGAGTT GGTGTTTGGA GCCCAGCCGC CCTCGGGCGC ACGGCCTGCC TGTCGCATGT TTGTGTCTGC
541 Leu Gln *
1720 CTCGTCCCCT CCCCTGGTGC CTGTGTCTGC AGAAAAACAA GACCAGATGT GATI'!lGTTT
FIG. 3. Nucleotide sequence and predicted amino acid sequence of the ,3 subunit of type II CaM kinase. The nucleotide sequence, covering
the region illustrated in Fig. 1, was compiled from analysis of seven overlapping fl-subunit cDNA clones. The predicted amino acid sequence
for the longest open reading frame is shown below the DNA sequence. The sequence enclosed in a box (nucleotides 1194-1238; nucleotides
1132-1176 in the coding sequence) is the region deleted from two independent clones. The region of sequence included in the comparison with
other protein kinases in Fig. 4 is underlined. The putative ATP-binding residue (Lys-43) is indicated by an asterisk. The entire region was
sequenced on both strands with each position having been determined an average of five times. Details of the sequencing strategy are presented
elsewhere (27).
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FIG. 4. Amino acid sequence alignment of the subunit of type II CaM kinase (Type Ii-p), the y subunit of phosphorylase b kinase (Pbk-y),
skeletal muscle myosin light chain kinase (MLCK), and the catalytic subunit of cAMP-dependent protein kinase (cAK-C). The sequences of
Pbk-y, MLCK, and cAK-C are from Reimann et al. (28), Takio et al. (29), and Shoji et al. (30), respectively. Residue numbers for each kinase
are indicated in parentheses at the beginning of each line. Sites of amino acid identity between the ,3-subunit sequence and the other kinases
are boxed, and gaps inserted to optimize alignment are indicated by dashes. The putative ATP-binding residue ofthe subunit (Lys-43) is marked
with an asterisk. The putative calmodulin-binding domains for the 1B subunit of type II CaM kinase (amino acids 295-315), the y subunit of
phosphorylase b kinase (amino acids 322-342), and skeletal muscle myosin light chain kinase (amino acids 342-360) are underlined by hatched
bars. Standard one-letter amino acid symbols are used.
amino acids are included in the comparison (31), the homol-
ogies are 58%, 52%, and 48% for the conserved domain of the
three kinases. Near the amino-terminal of the homologous
domain is a conserved lysine residue (asterisk in Fig. 4) that
is labeled in several protein kinases by photoaffinity ana-
logues ofATP (32-34). Lys-43 in the 13-subunit sequence is in
a position that corresponds to this lysine, and thus it may be
a component of the ATP binding site.
This region of the subunit is also highly homologous to
two recently published serine kinase sequences. It is identical
to the mammalian C-kinase (residues 343-595) at 30%o of its
residues (35, 36) and to the yeast snfl gene product (residues
59-306) at 38% of its residues (37). There are no homologies
to either of these proteins outside the conserved kinase
domain.
Calmodulin-Binding Domain. Calmodulin binding sites
from a number of calmodulin-dependent protein kinases have
been identified (38, 39). Although no consensus primary
sequence has emerged from these studies, there is a second-
ary structural feature, a basic amphiphilic a-helix, that is
common to many calmodulin-binding peptides (40). One
strongly basic region exists within the type II CaM kinase
(3subunit sequence (amino acids 295-315) which could form
an a-helix (41). Two-dimensional projections of this a-helix
(42) reveal that it has a basic surface (including three arginine
residues and one lysine residue) and a nonpolar surface
(including three alanines, one leucine, and one isoleucine)
that is similar in its amphiphilic nature to the calmodulin-
binding domains identified in other calmodulin-dependent
protein kinases (38, 39). This potential calmodulin-binding
domain (underlined sequence in Fig. 4) has only limited
homology with other protein kinases. However, it is posi-
tioned in the primary sequence near the putative calmodulin-
binding domains in skeletal muscle myosin light chain kinase
(38) and in phosphorylase b kinase (39) (also underlined in
Fig. 4).
DISCUSSION
We have used antibodies against the brain type II CaM kinase
to isolate cDNA clones coding for the 13 subunit. The coding
specificity of the clones was determined from the identity of
the protein synthesized from transcripts of the longest cDNA
(Fig. 2C) and from the differential distribution of the mes-
sages recognized by the clones in different brain regions (Fig.
2 A and B). The molecular weight (60,333) of the protein
coded for by the open reading frame (Fig. 3) is in close
agreement with that estimated for the subunit from its
mobility in NaDodSO4/polyacrylamide gels (1). Primer-
extension analysis indicates that the 1-subunit message
extends an additional 134 nucleotides beyond the 62 nucle-
otides of 5' untranslated sequence contained in the clones
(data not shown). Because the amino terminus of the P
subunit is blocked, we have not been able to directly confirm
the translation initiation site from the amino acid sequence.
However, the neighboring sequences of the first ATG codon
in the open reading frame are consistent with it being the true
start codon (43). Moreover, the X10,15-2 cDNA insert appears
to encode a full-length 1-subunit protein (Fig. 2C).
The deduced amino acid sequence ofthe subunit contains
a region of high homology to a number of other protein
kinases (Fig. 4). The homology is strongest to serine/
threonine-specific kinases. It is weaker to tyrosine-specific
kinases such as the oncogene kinases and cell surface
receptor kinases. Within this domain most of the kinases
contain a consensus sequence, Gly-Xaa-Gly-Xaa-Xaa-Gly,
16-28 residues amino-terminal to the ATP-binding lysine
residue. It has been proposed that this sequence is involved
in nucleotide binding (34). Within the 13-subunit sequence,
Lys-43 is in a position that corresponds to the ATP-binding
residue in other protein kinases; the sequence Gly-Xaa-Gly-
Xaa-Xaa-Ser begins at residue 21. The y subunit of phos-
phorylase kinase also contains a serine residue in place of the
third glycine in the consensus sequence. Therefore, this third
glycine may not be an absolute requirement for nucleotide
binding. The functions of the other regions of high homology
among protein kinases (Fig. 4) are not known.
Amino acid sequences outside the putative catalytic do-
main are not homologous among the various protein kinases
and are probably important for functions that are specific to
particular kinases, including regulatory interactions (35, 36,
Type II-O
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38, 44). Within the B-subunit sequence, we have identified
one potential regulatory domain, a calmodulin binding site
(Fig. 4). This domain shares the sequence Ala-Arg-Arg-Lys
with the calmodulin-binding peptide from smooth muscle
myosin light chain kinase (39) and the sequence Asn-Ala-
Arg-Arg-Lys-Leu-Lys with an unidentified brain calmodulin-
binding protein (47). The autophosphorylation sites that
control the generation of calcium-independent kinase activity
will also be important to identify (12). Of the 29 serine and 40
threonine residues within the (3 subunit, approximately 10
occur within the consensus sequence Arg/Lys-Xaa-Xaa-
Ser/Thr characteristic of phosphorylation sites on several
substrates of the type II CaM kinase (45) and thus are
potential autophosphorylation sites. Since peptide mapping
has shown that there are only three major calcium-dependent
autophosphorylation sites on the ( subunit (S. G. Miller and
M.B.K., unpublished observations), peptide sequencing will
be necessary to identify the relevant sites unambiguously.
Most purified preparations of brain type II CaM kinase
contain a minor subunit of molecular mass 58 kDa, which has
been termed the (3' subunit (1, 16, 26). Peptide maps suggest
that it is closely related to the (3 subunit (26, 46). Several
laboratories have suspected that this protein is generated by
artifactual proteolytic cleavage of the (3 subunit, although it
appears to be present in different amounts in different brain
regions (16, 26). Our results suggest an alternative hypothe-
sis. Two independent clones coding for the P subunit contain
a 45-nucleotide deletion in the region coding for the carboxyl
half of the subunit. The open reading frame present in these
clones codes for a 58-kDa protein that could be the ,(' subunit.
If these clones represent the sequence of a separate (3'
message, that message must result either from expression of
a ('-specific gene or from posttranscriptional processing of
the ,(-subunit message (alternative splicing). The sequence at
each end of the deletion is consistent with alternative splicing
of a single exon.
We thank Dr. D. Anderson for the gift of the X libraries and C.
Hochenedel and J. White for help with preparation of the manuscript.
This work was supported by National Institutes of Health Grants
NS17660 and IT32 GM07616, the McKnight Foundation, the Pugh
Foundation, and the Gustavus and Louise Pfeiffer Research Foun-
dation.
1. Bennett, M. K., Erondu, N. E. & Kennedy, M. B. (1983) J.
Biol. Chem. 258, 12735-12744.
2. Goldenring, J. R., Gonzales, B., McGuire, J. S., Jr. & DeLo-
renzo, R. J. (1983) J. Biol. Chem. 258, 12632-12640.
3. Erondu, N. E. & Kennedy, M. B. (1985) J. Neurosci. 5,
3270-3277.
4. McGuinness, T. L., Lai, Y., Greengard, P., Woodgett, J. R. &
Cohen, P. (1983) FEBS Lett. 163, 329-334.
5. Payne, M. E., Schworer, C. M. & Soderling, T. R. (1983) J.
Biol. Chem. 258, 2376-2382.
6. Ahmad, Z., DePaoli-Roach, A. A. & Roach, P. J. (1982) J.
Biol. Chem. 257, 8348-8355.
7. Ouimet, C. C., McGuinness, T. L. & Greengard, P. (1984)
Proc. NatI. Acad. Sci. USA 81, 5604-5608.
8. Kennedy, M. B., Bennett, M. K. & Erondu, N. E. (1983)
Proc. Nati. Acad. Sci. USA 80, 7357-7361.
9. Kelly, P. T., McGuinness, T. L. & Greengard, P. (1984) Proc.
Nati. Acad. Sci. USA 81, 945-949.
10. Goldenring, J. R., McGuire, J. S. & DeLorenzo, R. J. (1984)
J. Neurochem. 42, 1077-1084.
11. Saitoh, T. & Schwartz, J. H. (1985) J. Cell Biol. 100, 835-842.
12. Miller, S. G. & Kennedy, M. B. (1986) Cell 44, 861-870.
13. Young, R. A. & Davis, R. W. (1983) Proc. Natl. Acad. Sci.
USA 80, 1194-1198.
14. Huynh, T., Young, R. A. & Davis, R. W. (1985) in DNA
Cloning: A Practical Approach, ed. Glover, D. (Information
Retrieval, Oxford), pp. 49-78.
15. Moon, R. T., Ngai, J., Wold, B. J. & Lazarides, E. (1985) J.
Cell Biol. 100, 152-160.
16. Miller, S. G. & Kennedy, M. B. (1985) J. Biol. Chem. 260,
9039-9046.
17. Benton, W. D. & Davis, R. W. (1977) Science 196, 180-182.
18. Meinkoth, J. & Wahl, A. (1984) Anal. Biochem. 138, 267-284.
19. Maniatis, T., Fritsch, E. F. & Sambrook, J. (1982) Molecular
Cloning: A Laboratory Manual (Cold Spring Harbor Labora-
tory, Cold Spring Harbor, NY).
20. Messing, J. (1983) Methods Enzymol. 101, 20-78.
21. Sanger, F., Nicklen, S. & Coulson, A. R. (1977) Proc. Natl.
Acad. Sci. USA 74, 5463-5467.
22. Chirgwin, J. M., Pryzybyla, A. E., MacDonald, R. J. & Rut-
ter, W. J. (1979) Biochemistry 18, 5294-5299.
23. Aviv, H. & Leder, P. (1972) Proc. Natl. Acad. Sci. USA 69,
1408-1412.
24. Jackson, R. J. & Hunt, T. (1983) Methods Enzymol. 96, 50-74.
25. Melton, D. A., Krieg, P. A., Rebagliati, M. R., Maniatis, T.,
Zinn, K. & Green, M. R. (1984) Nucleic Acids Res. 12,
7035-7056.
26. McGuinness, T. L., Lai, Y. & Greengard, P. (1985) J. Biol.
Chem. 260, 1696-1704.
27. Bennett, M. K. (1986) Dissertation (California Institute of
Technology, Pasadena, CA).
28. Reimann, E. M., Titani, K., Ericsson, L. H., Wade, R. D.,
Fischer, E. H. & Walsh, K. A. (1984) Biochemistry 23, 4185-
4192.
29. Takio, K., Blumenthal, D. K., Edelman, A. M., Walsh,
K. A., Krebs, E. G. & Titani, K. (1985) Biochemistry 24,
6028-6037.
30. Shoji, S., Parmelee, D. C., Wade, R. D., Kumar, S., Ericsson,
L. H., Walsh, K. A., Neurath, H., Long, G. L., Demaille,
J. G., Fischer, E. H. & Titani, K. (1981) Proc. Natl. Acad.
Sci. USA 78, 848-851.
31. Dayhoff, M. O., Schwartz, R. M. & Orcutt, B. C. (1978) Atlas
of Protein Sequence and Structure 5, 345-352.
32. Zoller, M. J., Nelson, N. C. & Taylor, S. S. (1981) J. Biol.
Chem. 256, 10837-10842.
33. Hashimoto, E., Takio, K. & Krebs, E. G. (1982) J. Biol.
Chem. 257, 727-733.
34. Kamps, M. P., Taylor, S. S. & Sefton, B. M. (1984) Nature
(London) 310, 589-592.
35. Knopf, J. L., Lee, M.-H., Sultzman, L. A., Kriz, R. W.,
Loomis, C. R., Henwick, R. M. & Bell, R. M. (1986) Cell 46,
491-502.
36. Parker, P. J., Coussens, L., Totty, N., Rhee, L., Young, S.,
Chen, E., Stabel, S., Waterfield, M. D. & Ullrich, A. (1986)
Science 233, 853-859.
37. Celenza, J. L. & Carlson, M. (1986) Science 233, 1175-1180.
38. Blumenthal, D. K., Takio, K., Edelman, A. M., Charbon-
neau, H., Titani, K., Walsh, K. A. & Krebs, E. G. (1985)
Proc. Natl. Acad. Sci. USA 82, 3187-3191.
39. Lukas, T. J., Burgess, W. H., Prendergast, F. G., Lau, W. &
Watterson, D. M. (1986) Biochemistry 25, 1458-1464.
40. Cox, J. A., Comte, M., Fitton, J. E. & DeGrado, W. E. (1985)
J. Biol. Chem. 260, 2527-2534.
41. Chou, P. Y. & Fasman, G. D. (1978) Adv. Enzymol. Relat.
Areas Mol. Biol. 47, 45-148.
42. Schiffer, M. & Edmundson, A. B. (1967) Biophys. J. 7, 121-
135.
43. Kozak, M. (1986) Cell 44, 283-292.
44. Takio, K., Wade, R. D., Smith, S. B., Krebs, E. G., Walsh,
K. A. & Titani, K. (1984) Biochemistry 23, 4207-4218.
45. Pearson, R. B., Woodgett, J. R., Cohen, P. & Kemp, B. E.
(1985) J. Biol. Chem. 260, 14471-14476.
46. Kennedy, M. B., McGuinness, T. L. & Greengard, P. (1983)
J. Neurosci. 3, 818-831.
47. Sikela, J. M. & Hahn, W. E. (1986) Soc. Neurosci. Abstr. 12,
981 (abstr.).
Proc. Natl. Acad. Sci. USA 84 (1987)
